AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>

Table of contents of journal: *Chest

Results: 1-25/5580
UNTITLED
Authors: DALEN JE HIRSH J
Citation: Je. Dalen et J. Hirsh, UNTITLED, Chest, 114(5), 1998, pp. 2-2
INTRODUCTION - ANTITHROMBOTIC THERAPY - THE EVOLVING CONSENSUS - 1985TO 1998
Authors: DALEN JE HIRSH J
Citation: Je. Dalen et J. Hirsh, INTRODUCTION - ANTITHROMBOTIC THERAPY - THE EVOLVING CONSENSUS - 1985TO 1998, Chest, 114(5), 1998, pp. 439-440
GRADES OF RECOMMENDATION FOR ANTITHROMBOTIC AGENTS
Authors: GUYATT GH COOK DJ SACKETT DL ECKMAN M PAUKER S
Citation: Gh. Guyatt et al., GRADES OF RECOMMENDATION FOR ANTITHROMBOTIC AGENTS, Chest, 114(5), 1998, pp. 441-444
MECHANISM OF ACTION, CLINICAL EFFECTIVENESS, AND OPTIMAL THERAPEUTIC RANGE
Authors: HIRSH J DALEN JE ANDERSON DR POLLER L BUSSEY H ANSELL J DEYKIN D BRANDT JT
Citation: J. Hirsh et al., MECHANISM OF ACTION, CLINICAL EFFECTIVENESS, AND OPTIMAL THERAPEUTIC RANGE, Chest, 114(5), 1998, pp. 445-469
THE RELATIONSHIPS AMONG DOSE, EFFECTIVENESS, AND SIDE-EFFECTS
Authors: PATRONO C COLLER B DALEN JE FUSTER V GENT M HARKER LA HIRSH J ROTH G
Citation: C. Patrono et al., THE RELATIONSHIPS AMONG DOSE, EFFECTIVENESS, AND SIDE-EFFECTS, Chest, 114(5), 1998, pp. 470-488
HEPARIN AND LOW-MOLECULAR-WEIGHT HEPARIN - MECHANISMS OF ACTION, PHARMACOKINETICS, DOSING CONSIDERATIONS, MONITORING, EFFICACY, AND SAFETY
Authors: HIRSH J WARKENTIN TE RASCHKE R GRANGER C OHMAN EM DALEN JE
Citation: J. Hirsh et al., HEPARIN AND LOW-MOLECULAR-WEIGHT HEPARIN - MECHANISMS OF ACTION, PHARMACOKINETICS, DOSING CONSIDERATIONS, MONITORING, EFFICACY, AND SAFETY, Chest, 114(5), 1998, pp. 489-510
HEMORRHAGIC COMPLICATIONS OF ANTICOAGULANT TREATMENT
Authors: LEVINE MN RASKOB G LANDEFELD S KEARON C
Citation: Mn. Levine et al., HEMORRHAGIC COMPLICATIONS OF ANTICOAGULANT TREATMENT, Chest, 114(5), 1998, pp. 511-523
USE OF ANTITHROMBOTIC AGENTS DURING PREGNANCY
Authors: GINSBERG JS HIRSH J
Citation: Js. Ginsberg et J. Hirsh, USE OF ANTITHROMBOTIC AGENTS DURING PREGNANCY, Chest, 114(5), 1998, pp. 524-530
PREVENTION OF VENOUS THROMBOEMBOLISM
Authors: CLAGETT GP ANDERSON FA GEERTS W HEIT JA KNUDSON M LIEBERMAN JR MERLI GJ WHEELER HB
Citation: Gp. Clagett et al., PREVENTION OF VENOUS THROMBOEMBOLISM, Chest, 114(5), 1998, pp. 531-560
ANTITHROMBOTIC THERAPY FOR VENOUS THROMBOEMBOLIC DISEASE
Authors: HYERS TM AGNELLI G HULL RD WEG JG MORRIS TA SAMAMA M TAPSON V
Citation: Tm. Hyers et al., ANTITHROMBOTIC THERAPY FOR VENOUS THROMBOEMBOLIC DISEASE, Chest, 114(5), 1998, pp. 561-578
ANTITHROMBOTIC THERAPY IN ATRIAL-FIBRILLATION
Authors: LAUPACIS A ALBERS G DALEN J DUNN MI JACOBSON AK SINGER DE
Citation: A. Laupacis et al., ANTITHROMBOTIC THERAPY IN ATRIAL-FIBRILLATION, Chest, 114(5), 1998, pp. 579-589
ANTITHROMBOTIC THERAPY IN VALVULAR HEART-DISEASE
Authors: SALEM DN LEVINE HJ PAUKER SG ECKMAN MH DAUDELIN DH
Citation: Dn. Salem et al., ANTITHROMBOTIC THERAPY IN VALVULAR HEART-DISEASE, Chest, 114(5), 1998, pp. 590-601
ANTITHROMBOTIC THERAPY IN PATIENTS WITH MECHANICAL AND BIOLOGICAL PROSTHETIC HEART-VALVES
Authors: STEIN PD ALPERT JS DALEN JE HORSTKOTTE D TURPIE AGG
Citation: Pd. Stein et al., ANTITHROMBOTIC THERAPY IN PATIENTS WITH MECHANICAL AND BIOLOGICAL PROSTHETIC HEART-VALVES, Chest, 114(5), 1998, pp. 602-610
ANTITHROMBOTIC AGENTS IN CORONARY-ARTERY DISEASE
Authors: CAIRNS JA THEROUX P LEWIS HD EZEKOWITZ M MEADE TW SUTTON GC
Citation: Ja. Cairns et al., ANTITHROMBOTIC AGENTS IN CORONARY-ARTERY DISEASE, Chest, 114(5), 1998, pp. 611-633
CORONARY THROMBOLYSIS
Authors: CAIRNS JA KENNEDY JW FUSTER V
Citation: Ja. Cairns et al., CORONARY THROMBOLYSIS, Chest, 114(5), 1998, pp. 634-657
ANTITHROMBOTIC THERAPY IN PATIENTS WITH SAPHENOUS-VEIN AND INTERNAL MAMMARY ARTERY BYPASS GRAFTS
Authors: STEIN PD DALEN JE GOLDMAN S THEROUX P
Citation: Pd. Stein et al., ANTITHROMBOTIC THERAPY IN PATIENTS WITH SAPHENOUS-VEIN AND INTERNAL MAMMARY ARTERY BYPASS GRAFTS, Chest, 114(5), 1998, pp. 658-665
ANTITHROMBOTIC THERAPY IN PERIPHERAL ARTERIAL OCCLUSIVE DISEASE
Authors: JACKSON MR CLAGETT GP
Citation: Mr. Jackson et Gp. Clagett, ANTITHROMBOTIC THERAPY IN PERIPHERAL ARTERIAL OCCLUSIVE DISEASE, Chest, 114(5), 1998, pp. 666-682
ANTITHROMBOTIC AND THROMBOLYTIC THERAPY FOR ISCHEMIC STROKE
Authors: ALBERS GW EASTON JD SACCO RL TEAL P
Citation: Gw. Albers et al., ANTITHROMBOTIC AND THROMBOLYTIC THERAPY FOR ISCHEMIC STROKE, Chest, 114(5), 1998, pp. 683-698
MAKING DECISIONS ABOUT ANTITHROMBOTIC THERAPY IN HEART-DISEASE - DECISION-ANALYTIC AND COST-EFFECTIVENESS ISSUES
Authors: ECKMAN MH LEVINE HJ SALEM DN PAUKER SG
Citation: Mh. Eckman et al., MAKING DECISIONS ABOUT ANTITHROMBOTIC THERAPY IN HEART-DISEASE - DECISION-ANALYTIC AND COST-EFFECTIVENESS ISSUES, Chest, 114(5), 1998, pp. 699-714
NEW ANTITHROMBOTIC AGENTS
Authors: WEITZ JI HIRSH J
Citation: Ji. Weitz et J. Hirsh, NEW ANTITHROMBOTIC AGENTS, Chest, 114(5), 1998, pp. 715-727
ANTITHROMBOTIC THERAPY IN PATIENTS UNDERGOING CORONARY ANGIOPLASTY
Authors: POPMA JJ WEITZ J BITTL JA OHMAN M KUNTZ RE LANSKY AJ KING SB
Citation: Jj. Popma et al., ANTITHROMBOTIC THERAPY IN PATIENTS UNDERGOING CORONARY ANGIOPLASTY, Chest, 114(5), 1998, pp. 728-741
MEDICOLEGAL IMPLICATIONS OF THE CONSENSUS CONFERENCE, WITH SPECIAL ATTENTION TO THE 5TH ANTITHROMBOTIC-THERAPY-CONSENSUS-CONFERENCE
Authors: MCINTYRE KM
Citation: Km. Mcintyre, MEDICOLEGAL IMPLICATIONS OF THE CONSENSUS CONFERENCE, WITH SPECIAL ATTENTION TO THE 5TH ANTITHROMBOTIC-THERAPY-CONSENSUS-CONFERENCE, Chest, 114(5), 1998, pp. 742-747
ANTITHROMBOTIC THERAPY IN CHILDREN
Authors: MICHELSON AD BOVILL E MONAGLE P ANDREW M
Citation: Ad. Michelson et al., ANTITHROMBOTIC THERAPY IN CHILDREN, Chest, 114(5), 1998, pp. 748-769
OF PRIDE AND PROGRAM-PLANNING - A LESSON IN REALITY
Authors: SBARBARO JA
Citation: Ja. Sbarbaro, OF PRIDE AND PROGRAM-PLANNING - A LESSON IN REALITY, Chest, 114(5), 1998, pp. 1229-1230
ADJUNCTIVE CORTICOSTEROID-THERAPY FOR PNEUMOCYSTIS-CARINII PNEUMONIA
Authors: POTTRATZ ST
Citation: St. Pottratz, ADJUNCTIVE CORTICOSTEROID-THERAPY FOR PNEUMOCYSTIS-CARINII PNEUMONIA, Chest, 114(5), 1998, pp. 1230-1231
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>